Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Fujian Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 26 active clinical trials for multiple myeloma hosted across 6 tertiary medical centers in Fujian (including 福建医科大学附属协和医院, The First Affiliated Hospital of Xiamen University, Zhongshan Hospital Xiamen University, etc.).
Participating Medical Centers (6)
Active Studies in Fujian (26)
Population synthesized by CMDNShowing 0 published English records of 26 registry trials.
All 26 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.